Faculty Bibliography

The vaccine with some weakened doses was Fluogen, made by the Parke-Davis division of Warner Lambert Co. Eleven lots distributed to all 50 states and the District of Columbia lost potency, said Stephen Mock, a spokesman for Warner Lambert. Parke-Davis is one of four manufacturers of influenza vaccine used in this country. Parke-Davis made a total of 13 million doses of the vaccine, or about 18 percent of the U.S. supply, Mock said. Parke-Davis's vaccine is safe, but the problem is its lowered potency, [David A. Kessler] said. In recent weeks, Parke-Davis found in tests of people who had received shots from the 11 lots that the ability of the vaccine to promote resistance to one of the three influenza strains was about 25 percent to 30 percent lower than the recommended standard, Kessler said. The strain, Nanchang, is the one that is causing many of the current cases of influenza, Kessler and officials of the centers said

Because 5.8 million of the 75 million doses of flu vaccine produced in 1996 were not full strength, federal health officials on Dec 17, 1996 advised doctors to consider giving another flu shot to roughly two million recipients who are at highest risk from complication of the viral infection. People over 65 and those with chronic heart and lung disease are among those considered at highest risk

In the year since an AIDS patient in San Francisco received an experimental transplant of baboon bone marrow, he has gained weight and strength, and remained free of severe infections, even though the transplant did not take. The transplanted baboon cells stayed in [Jeff] Getty's body for about two weeks and failed to grow. 'Clearly, the baboon bone marrow transplant did not take,' said Dr. Paul Volberding, a member of Getty's research team at San Francisco General Hospital and the University of California, where the experimental procedure was performed. Yet Getty's astonishing improvement has led the University of California researchers to design new experiments aimed at restoring immune function. The new studies focus on the radiation and chemotherapy that he received to kill some cells in his marrow to make space for the baboon cells. The new experiments also include combinations of drugs that attack HIV, the virus that causes AIDS

The transplanted baboon cells stayed in Mr. [Jeff Getty]'s body for about two weeks and failed to grow. 'Clearly, the baboon bone marrow transplant did not take,' said Dr. Paul Volberding, a member of Mr. Getty's research team at San Francisco General Hospital and the University of California, where the experimental procedure was performed

Jeff Getty, a San Francisco AIDS patient who received a baboon bone marrow transplant in 1995, has seen vast improvements in his health in the year since the transplant. Scientists are unable to determine the exact cause of Getty's improved health since his body rejected the transplant and he used other forms of treatment in conjunction with the transplant

In the year since an AIDS patient in San Francisco received an experimental transplant of baboon bone marrow, he has gained weight and strength and remained free of severe infections, even though the transplant did not take. The transplanted baboon cells stayed in Getty's body for about two weeks and failed to grow. ``Clearly, the baboon bone-marrow transplant did not take,'' said Dr. Paul Volberding, a member of Getty's research team at San Francisco General Hospital and the University of California, where the experimental procedure was performed

In the year since an AIDS patient in San Francisco received an experimental transplant of baboon bone marrow, he has gained weight and strength and remained free of severe infections, even though the transplant did not take. [Jeff] Getty, a 39-year-old from Oakland, has gained 17 pounds, bringing his weight to 172, has become strong enough to bench-press 180 pounds, has traveled to Europe and has escaped new bouts of the serious opportunistic infections that had threatened his life before the procedure. The transplanted baboon cells stayed in Getty's body for about two weeks and failed to grow. 'Clearly, the baboon bone marrow transplant did not take,' said Dr. Paul Volberding, a member of Getty's University of California research team at San Francisco General Hospital, where the experimental procedure was performed

Russian President Boris Yeltsin's heart function has improved significantly since his bypass surgery in Nov 1996 and his recuperation continues smoothly, according to an American consultant in Yeltsin's case

A modification of standard CT scan X-rays that are available in most large hospitals promises to enable doctors to diagnose appendicitis more accurately and to reduce the number of appendectomies significantly, radiologists from Boston told a scientific meeting of the Radiological Society of North America in Chicago on Dec 3, 1996. The technique, called FACT (Focused appendix CT), involves inserting a dye through a tube in the rectum to show the appendix